Prostatis Group’s ARK Innovation ETF ARKK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,594
Closed -$664K 99
2022
Q3
$664K Buy
+17,594
New +$783K 0.77% 33
2022
Q2
Sell
-24,693
Closed -$1.64M 49
2022
Q1
$1.64M Buy
24,693
+3,952
+19% +$279K 1.31% 25
2021
Q4
$1.96M Buy
20,741
+1,413
+7% +$154K 1.2% 26
2021
Q3
$2.14M Buy
19,328
+1,156
+6% +$139K 1.28% 26
2021
Q2
$2.38M Buy
18,172
+2,495
+16% +$291K 1.62% 17
2021
Q1
$1.88M Buy
15,677
+763
+5% +$103K 1.48% 18
2020
Q4
$1.86M Buy
14,914
+5,761
+63% +$625K 1.55% 17
2020
Q3
$842K Buy
+9,153
New +$783K 0.8% 34

Other funds holding ARKK

Prostatis Group's ARKK Position: Q4 2022 in Review

Prostatis Group sold out of ARK Innovation ETF (ARKK) in Q4 2022, closing a stake of 17,594 shares — an estimated $664K sold.

Prostatis Group first reported a position in ARKK in Q3 2020 and held it in 8 quarters. The position peaked at $2.38M in Q2 2021. 596 funds tracked by Wall St. Rank hold ARKK as of Q4 2022.

  • Prostatis Group reported no remaining ARK Innovation ETF position as of Q4 2022 after selling out during the quarter.
  • Prostatis Group sold 17,594 ARK Innovation ETF shares in Q4 2022, an estimated $664K.
  • Prostatis Group first reported a position in ARK Innovation ETF in Q3 2020 and held it in 8 quarters.
  • Prostatis Group's ARK Innovation ETF position peaked at $2.38M in Q2 2021.
  • 596 funds tracked by Wall St. Rank held ARK Innovation ETF as of Q4 2022.

Based on Prostatis Group's 13F filing for Q4 2022, filed 23 Mar 2023.